ConvaTec Group (LON:CTEC) Earns Buy Rating from Deutsche Bank Aktiengesellschaft

Key Points

• Deutsche Bank Aktiengesellschaft has reaffirmed a "buy" rating for ConvaTec Group (LON:CTEC) with a price target of GBX 315 ($4.21), indicating a potential upside of 34.05%.
• Other research firms, including JPMorgan and Peel Hunt, also maintain positive outlooks, contributing to a consensus rating of "Buy" with an average price target of GBX 303.40 ($4.05).
• ConvaTec Group, which specializes in medical products for wound management, currently has a market capitalization of £5.98 billion and a P/E ratio of 39.57.

ConvaTec Group (LON:CTEC - Get Free Report)'s stock had its "buy" rating reaffirmed by equities researchers at Deutsche Bank Aktiengesellschaft in a report issued on Wednesday, Marketbeat Ratings reports. They currently have a GBX 315 ($4.18) price target on the stock. Deutsche Bank Aktiengesellschaft's price objective would suggest a potential upside of 36.54% from the company's previous close.

Other equities analysts also recently issued reports about the stock. JPMorgan Chase & Co. reaffirmed an "overweight" rating on shares of ConvaTec Group in a research note on Wednesday. Peel Hunt restated an "add" rating and set a GBX 280 ($3.72) target price on shares of ConvaTec Group in a report on Tuesday, July 29th.

ConvaTec Group Stock Down 1.2%

LON:CTEC traded down GBX 2.70 ($0.04) during trading hours on Wednesday, hitting GBX 230.70 ($3.06). 10,209,894 shares of the stock traded hands, compared to its average volume of 14,010,055. The firm has a 50 day moving average price of GBX 270.11 and a 200 day moving average price of GBX 259.23. The company has a current ratio of 2.26, a quick ratio of 0.96 and a debt-to-equity ratio of 85.32. ConvaTec Group has a fifty-two week low of GBX 211.80 ($2.81) and a fifty-two week high of GBX 311.20 ($4.13). The firm has a market cap of £5.87 billion, a price-to-earnings ratio of 38.85, a PEG ratio of 0.93 and a beta of 0.64.

ConvaTec Group Company Profile

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.